Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Carmat SAS grosses €15.5mm through its IPO

Executive Summary

Two-year-old artificial heart developer Carmat SAS has grossed €15.5mm ($19.6mm) through the initial public offering of 827k shares (including the option clause) at €18.75 (mid-way between its proposed €17.35-20.15 range) on the Alternext of NYSE Euronext Paris. The company had hoped to bring in up to €19.8mm.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies